Skip to main content
. 2018 Aug 16;19:291. doi: 10.1186/s12891-018-2221-5

Fig. 1.

Fig. 1

Study design. The right knee joint had an intra-articular injection of MIA at day 0. The left knee had PBS as a control. Histological and immunohistochemical evaluations (hematoxylin and eosin/safranin O staining and calcitonin gene-related peptide staining) were performed at 5, 14, and 28 days post-injection. The pain avoidance behavior tests (incapacitance and von Frey) were performed as indicated